Immunology

Immunology Today—May 6, 2026

This week’s Immunology update highlights regulatory approvals, Phase 3…


Hematology

Hematology Today—May 4, 2026

This week’s Hematology update highlights regulatory progress, clinical data…


Immunology

Immunology Today—April 29, 2026

This week’s Immunology update highlights regulatory actions, clinical progress,…


Neuroscience

Neuroscience Today—April 29, 2026

This week’s Neuroscience update highlights regulatory actions, clinical…


Cell_Gene_Therapy

Cell and Gene Therapy Today—April 23, 2026

This week’s Gene and Cell Therapy update highlights regulatory momentum,…


Immunology

Immunology Today—April 1, 2026

This week’s Immunology update highlights regulatory progress, late-stage…


Lucid Diligence Brief - BioPharma

Lucid Diligence Brief: Royalty Pharma and J&J partner in a $500M R&D deal for JNJ-4804

Lucid Diligence Brief: Royalty Pharma and J&J partner in a $500M R&D…


Immunology

Immunology Today—March 25, 2026

This week’s Immunology update highlights regulatory progress, dermatology…


Hematology

Hematology Today—March 16, 2026

This week’s Hematology update highlights regulatory filings, positive…


Immunology

Immunology Video Recap—March 11, 2026

This biweekly Immunology video recap highlights regulatory approvals,…


Immunology

Immunology Today—March 11, 2026

This week’s Immunology update highlights regulatory progress, positive…


Hematology

Hematology Video Recap—March 9, 2026

This biweekly Hematology video recap highlights regulatory approvals, priority…


Privacy Preference Center